Cargando…
Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease
Oxidative stress is a key contributing factor in the complex degenerating cascade in Parkinson’s disease. The inhibition of MAO-B affords higher dopamine bioavailability and stops ROS formation. The incorporation of hydroxy and methoxy groups in the arylhydrazone moiety of a new series of 1,3-disubs...
Autores principales: | Anastassova, Neda, Aluani, Denitsa, Hristova-Avakumova, Nadya, Tzankova, Virginia, Kondeva-Burdina, Magdalena, Rangelov, Miroslav, Todorova, Nadezhda, Yancheva, Denitsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138090/ https://www.ncbi.nlm.nih.gov/pubmed/35624746 http://dx.doi.org/10.3390/antiox11050884 |
Ejemplares similares
-
Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation
por: Anastassova, Neda, et al.
Publicado: (2021) -
New Indole-3-Propionic Acid and 5-Methoxy-Indole Carboxylic Acid Derived Hydrazone Hybrids as Multifunctional Neuroprotectors
por: Anastassova, Neda, et al.
Publicado: (2023) -
In Silico Evaluation and In Vitro Determination of Neuroprotective and MAO-B Inhibitory Effects of Pyrrole-Based Hydrazones: A Therapeutic Approach to Parkinson’s Disease
por: Kondeva-Burdina, Magdalena, et al.
Publicado: (2022) -
New 1H-benzimidazole-2-yl hydrazones with combined antiparasitic and antioxidant activity
por: Argirova, Maria A., et al.
Publicado: (2021) -
Modulation Effect on Tubulin Polymerization, Cytotoxicity and Antioxidant Activity of 1H-Benzimidazole-2-Yl Hydrazones
por: Argirova, Maria, et al.
Publicado: (2022)